# PR-7 (NCT00003653)

> Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: buserelin; goserelin; leuprolide
- Indication: prostate cancer with rising PSA after radiotherapy

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00003653
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: NCIC Clinical Trials Group
- Conditions: Prostate Cancer
- Interventions: bicalutamide; buserelin; cyproterone acetate; flutamide; goserelin; leuprolide acetate; nilutamide
- Enrollment: 1386
- Primary outcome: Overall survival

## Indexed commentary on PR-7 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 9 YouTube videos
- 5 posts on X
- 4 podcast episodes

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=pr-7-nct00003653

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00003653", "email": "<work email>"}; the inbox owner confirms by the emailed link.